These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

125 related items for PubMed ID: 2512516

  • 1. Treatment with a selective MAO B inhibitor prevents loss of dopamine in the nucleus accumbens of MPTP-treated common marmosets.
    Rose S, Nomoto M, Jackson EA, Gibb WR, Jenner P, Marsden CD.
    Neuropharmacology; 1989 Nov; 28(11):1211-6. PubMed ID: 2512516
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Transient depletion of nucleus accumbens dopamine content may contribute to initial akinesia induced by MPTP in common marmosets.
    Rose S, Nomoto M, Jenner P, Marsden CD.
    Biochem Pharmacol; 1989 Nov 01; 38(21):3677-81. PubMed ID: 2597167
    [Abstract] [Full Text] [Related]

  • 4. Further treatment with MPTP does not produce parkinsonism in marmosets showing behavioural recovery from motor deficits induced by an earlier exposure to the toxin.
    Ueki A, Chong PN, Albanese A, Rose S, Chivers JK, Jenner P, Marsden CD.
    Neuropharmacology; 1989 Oct 01; 28(10):1089-97. PubMed ID: 2510050
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Striatal dopaminergic correlates of stable parkinsonism and degree of recovery in old-world primates one year after MPTP treatment.
    Elsworth JD, Taylor JR, Sladek JR, Collier TJ, Redmond DE, Roth RH.
    Neuroscience; 2000 Oct 01; 95(2):399-408. PubMed ID: 10658619
    [Abstract] [Full Text] [Related]

  • 11. Comparison of the effects of two 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine analogs, 1-methyl-4-(2-thienyl)-1,2,3,6-tetrahydropyridine and 1-methyl-4-(3-thienyl)-1,2,3,6-tetrahydropyridine, on monoamine oxidase in vitro and on dopamine in mouse brain.
    Fuller RW, Robertson DW, Hemrick-Luecke SK.
    J Pharmacol Exp Ther; 1987 Feb 01; 240(2):415-20. PubMed ID: 3100775
    [Abstract] [Full Text] [Related]

  • 12. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset.
    Jenner P, Rupniak NM, Rose S, Kelly E, Kilpatrick G, Lees A, Marsden CD.
    Neurosci Lett; 1984 Sep 07; 50(1-3):85-90. PubMed ID: 6436758
    [Abstract] [Full Text] [Related]

  • 13. Prevention of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced dopaminergic toxicity in mice by MDL 72145, a selective inhibitor of MAO-B.
    Kindt MV, Heikkila RE.
    Life Sci; 1986 Apr 21; 38(16):1459-62. PubMed ID: 3084895
    [Abstract] [Full Text] [Related]

  • 14. Alterations in striatal and extrastriatal D-1 and D-2 dopamine receptors in the MPTP-treated common marmoset: an autoradiographic study.
    Gnanalingham KK, Smith LA, Hunter AJ, Jenner P, Marsden CD.
    Synapse; 1993 Jun 21; 14(2):184-94. PubMed ID: 8332947
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Attenuation of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) neurotoxicity by the novel selective dopamine D3-receptor partial agonist FAUC 329 predominantly in the nucleus accumbens of mice.
    Boeckler F, Leng A, Mura A, Bettinetti L, Feldon J, Gmeiner P, Ferger B.
    Biochem Pharmacol; 2003 Sep 15; 66(6):1025-32. PubMed ID: 12963489
    [Abstract] [Full Text] [Related]

  • 17. Increased dopamine turnover in the putamen after MPTP treatment in common marmosets.
    Nomoto M, Iwata SI, Kaseda S, Fukuda T, Nakagawa S.
    Brain Res; 1997 Sep 05; 767(2):235-8. PubMed ID: 9367253
    [Abstract] [Full Text] [Related]

  • 18. The evolution of nigrostriatal neurochemical changes in the MPTP-treated squirrel monkey.
    Irwin I, DeLanney LE, Forno LS, Finnegan KT, Di Monte DA, Langston JW.
    Brain Res; 1990 Oct 29; 531(1-2):242-52. PubMed ID: 1981162
    [Abstract] [Full Text] [Related]

  • 19. Dopaminergic neurotoxicity of 1-methyl-4-phenyl-1,2,5,6-tetrahydropyridine (MPTP) in the mouse: relationships between monoamine oxidase, MPTP metabolism and neurotoxicity.
    Heikkila RE, Hess A, Duvoisin RC.
    Life Sci; 1985 Jan 21; 36(3):231-6. PubMed ID: 3917525
    [Abstract] [Full Text] [Related]

  • 20. Effects of bifemelane on parkinsonism induced by 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) in the common marmoset.
    Nomoto M, Irifune M, Fukuzaki K, Fukuda T.
    Neurosci Lett; 1994 Aug 29; 178(1):95-8. PubMed ID: 7816348
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.